Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 143,285
  • Shares Outstanding, K 151,448
  • Annual Sales, $ 126,330 K
  • Annual Income, $ -113,720 K
  • 60-Month Beta 2.02
  • Price/Sales 1.11
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MCRB with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.60
  • Most Recent Earnings $-0.22 on 08/13/24
  • Next Earnings Date 11/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 175.24% ( +3.60%)
  • Historical Volatility 99.73%
  • IV Percentile 55%
  • IV Rank 23.69%
  • IV High 652.30% on 04/17/24
  • IV Low 27.12% on 01/11/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 1,636
  • Volume Avg (30-Day) 3,649
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 48,007
  • Open Int (30-Day) 38,868

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 3
  • High Estimate -0.23
  • Low Estimate -0.26
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +35.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7700 +24.84%
on 09/04/24
1.3200 -27.17%
on 09/06/24
+0.1607 (+20.07%)
since 08/30/24
3-Month
0.6957 +38.18%
on 07/03/24
1.5300 -37.17%
on 07/18/24
+0.2393 (+33.14%)
since 07/01/24
52-Week
0.5400 +78.02%
on 04/19/24
2.3800 -59.61%
on 10/02/23
-1.4187 (-59.61%)
since 09/29/23

Most Recent Stories

More News
Seres Therapeutics: Q2 Earnings Snapshot

Seres Therapeutics: Q2 Earnings Snapshot

MCRB : 0.9613 (+1.61%)
Seres Therapeutics: Q1 Earnings Snapshot

Seres Therapeutics: Q1 Earnings Snapshot

MCRB : 0.9613 (+1.61%)
Seres Therapeutics: Q3 Earnings Snapshot

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.9613 (+1.61%)
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 28.67 (-1.58%)
FHTX : 8.67 (-6.87%)
MRNA : 63.93 (-4.34%)
OMGA : 1.2000 (-1.64%)
SANA : 4.24 (+1.92%)
MCRB : 0.9613 (+1.61%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFoundâ„¢ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 28.67 (-1.58%)
FHTX : 8.67 (-6.87%)
MRNA : 63.93 (-4.34%)
OMGA : 1.2000 (-1.64%)
SANA : 4.24 (+1.92%)
MCRB : 0.9613 (+1.61%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 28.67 (-1.58%)
FHTX : 8.67 (-6.87%)
MRNA : 63.93 (-4.34%)
OMGA : 1.2000 (-1.64%)
SANA : 4.24 (+1.92%)
MCRB : 0.9613 (+1.61%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 28.67 (-1.58%)
FHTX : 8.67 (-6.87%)
MRNA : 63.93 (-4.34%)
OMGA : 1.2000 (-1.64%)
SANA : 4.24 (+1.92%)
MCRB : 0.9613 (+1.61%)
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...

DNLI : 28.67 (-1.58%)
FHTX : 8.67 (-6.87%)
MRNA : 63.93 (-4.34%)
OMGA : 1.2000 (-1.64%)
SANA : 4.24 (+1.92%)
MCRB : 0.9613 (+1.61%)
Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...

DNLI : 28.67 (-1.58%)
FHTX : 8.67 (-6.87%)
MRNA : 63.93 (-4.34%)
OMGA : 1.2000 (-1.64%)
SANA : 4.24 (+1.92%)
MCRB : 0.9613 (+1.61%)
Seres Therapeutics: Q2 Earnings Snapshot

Seres Therapeutics: Q2 Earnings Snapshot

MCRB : 0.9613 (+1.61%)

Business Summary

Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 1.1842
2nd Resistance Point 1.0751
1st Resistance Point 1.0182
Last Price 0.9613
1st Support Level 0.8522
2nd Support Level 0.7431
3rd Support Level 0.6862

See More

52-Week High 2.3800
Fibonacci 61.8% 1.6771
Fibonacci 50% 1.4600
Fibonacci 38.2% 1.2429
Last Price 0.9613
52-Week Low 0.5400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar